Cargando…
Heteronemin Suppresses Lymphangiogenesis through ARF-1 and MMP-9/VE-Cadherin/Vimentin
Lymphatic metastasis is a biological procedure associated with the pathogenesis of several diseases, especially in tumor metastasis. Therefore, regulation of lymphangiogenesis has become a promising strategy for cancer therapy. In this study, we aimed to investigate the anti-lymphangiogenic effect o...
Autores principales: | Chen, Hsien-Lin, Su, Yu-Chieh, Chen, Huang-Chi, Su, Jui-Hsin, Wu, Chang-Yi, Wang, Shih-Wei, Lin, In-Pin, Chen, Chung-Yi, Lee, Chien-Hsing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8471334/ https://www.ncbi.nlm.nih.gov/pubmed/34572295 http://dx.doi.org/10.3390/biomedicines9091109 |
Ejemplares similares
-
The power of heteronemin in cancers
por: Wang, Kuan, et al.
Publicado: (2022) -
Improvement and enhancement of antibladder carcinoma cell effects of heteronemin by the nanosized hyaluronan aggregation
por: Huang, Han Hsiang, et al.
Publicado: (2016) -
Heteronemin Induces Anti-Proliferation in Cholangiocarcinoma Cells via Inhibiting TGF-β Pathway
por: Lin, Hung-Yun, et al.
Publicado: (2018) -
Combined Treatment of Heteronemin and Tetrac Induces Antiproliferation in Oral Cancer Cells
por: Huang, Chi-Hung, et al.
Publicado: (2020) -
Differential Localization of VE- and N-Cadherins in Human Endothelial Cells: VE-Cadherin Competes with N-Cadherin for Junctional Localization
por: Navarro, Pilar, et al.
Publicado: (1998)